Neurocrine Biosciences Aktie

Neurocrine Biosciences für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 900964 / ISIN: US64125C1099

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
05.05.2025 22:04:11

Neurocrine Biosciences Inc Q1 Profit Decreases, Misses Estimates

(RTTNews) - Neurocrine Biosciences Inc (NBIX) announced earnings for first quarter that decreased from the same period last year and missed the Street estimates.

The company's earnings came in at $7.9 million, or $0.08 per share. This compares with $43.4 million, or $0.42 per share, last year.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $71.5 million or $0.70 per share for the period.

Analysts on average had expected the company to earn $1.09 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 11.1% to $572.6 million from $515.3 million last year.

Neurocrine Biosciences Inc earnings at a glance (GAAP) :

-Earnings: $7.9 Mln. vs. $43.4 Mln. last year. -EPS: $0.08 vs. $0.42 last year. -Revenue: $572.6 Mln vs. $515.3 Mln last year.

Analysen zu Neurocrine Biosciences Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Neurocrine Biosciences Inc. 122,70 1,57% Neurocrine Biosciences Inc.